Episode Details

Peptides. Animal-derived thyroid products. The perils of not documenting enough. A new recommendation for state regulation. And more.

Besides the most interesting (and important) news from the pharmacy compounding world, this episode we’ve got a deep dive into the unique tax issues compounders face — which can be pretty darned daunting.

Links from the episode
APC issue brief on peptide compounding (two-page PDF): https://fllw.me/47mZu7b
Citizen petition to FDA on compounding ADT (83-page (!) PDF): https://fllw.me/3VeA9tw
FDA’s proposed GFI 256B — info and a chance to comment: https://www.regulations.gov/search?searchTerm=FDA-2018-D-4533
APC’s exclusive processing rates: https://apcpayments.com
NABP’s model pharmacy act: https://nabp.pharmacy/members/board-resources/model-pharmacy-act-rules/
Sykes & Company Pharmacy Accounting Services: https://www.sykes-cpa.com/compounding-pharmacy-services